Open-mkt buys · 90d
$59.0K
6 trades · 3 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$59.0K
Insiders on file
23
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Frankel Stanley | Director | 16 | $38.1K | $0 | 2026-09-28 |
| Brown Melinda | Director | 18 | $57.4K | $0 | 2026-09-25 |
| Germano Geno J | Director | 18 | $80.3K | $0 | 2026-09-25 |
| Pire Shari Lisa | Director | 12 | $0 | $0 | 2026-06-03 |
| Buehler Kevin | Director | 21 | $63.3K | $0 | 2026-06-03 |
| Amoroso Michael | President and CEO | 51 | $0 | $616.5K | 2026-06-01 |
| Scimeca Dario | General Counsel and Secretary | 71 | $0 | $169.1K | 2026-06-01 |
| SMITH J. JEFFERSON | Chief Research Officer | 40 | $0 | $122.6K | 2026-06-01 |
| Kelly John Alexander | Chief Financial Officer | 67 | $252.5K | $164.2K | 2026-06-01 |
| Wadsworth Samuel C. | Director | 6 | $0 | $0 | 2024-06-04 |
| List Alan | Chief Medical Officer | 23 | $0 | $45.7K | 2024-05-02 |
| Barton Shane | VP & Corporate Controller | 14 | $0 | $0 | 2023-06-07 |
| JANTZ DEREK | Chief Scientific Officer | 63 | $0 | $1.62M | 2022-06-08 |
| Schinazi Raymond F | Director | 9 | $0 | $0 | 2022-05-10 |
| THOMSON DAVID S. | Chief Operating Officer | 23 | $0 | $1.24M | 2021-06-23 |
| KHAZI FAYAZ | CEO of Elo Life Systems | 4 | $0 | $0 | 2021-06-07 |
| KANE MATTHEW R. | President and CEO | 54 | $0 | $1.61M | 2021-06-07 |
| Sharp Shalini | Director | 2 | $0 | $0 | 2021-05-10 |
| ANSARI ABID | Chief Financial Officer | 16 | $0 | $0 | 2020-06-15 |
| Heery Christopher | Chief Medical Officer | 3 | $30.0K | $0 | 2020-06-08 |
| YAO TONY DUNG LING | Director | 10 | $100.0K | $0 | 2019-04-03 |
| FMR LLC | Other | 5 | $800.0K | $0 | 2019-04-01 |
| venBio Global Strategic GP, Ltd. | 10% Owner | 5 | $800.0K | $0 | 2019-04-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Frankel Stanley | Director | P Buy | 2026-09-28 | 2026-09-30 | 1,000 | $6.00 | $6.0K | 41,478 | SEC↗ |
| Frankel Stanley | Director | P Buy | 2026-09-28 | 2026-09-30 | 1,000 | $6.00 | $6.0K | 41,478 | SEC↗ |
| Germano Geno J | Director | P Buy | 2026-09-25 | 2026-09-29 | 2,609 | $6.28 | $16.4K | 47,492 | SEC↗ |
| Brown Melinda | Director | P Buy | 2026-09-25 | 2026-09-29 | 1,135 | $6.27 | $7.1K | 45,481 | SEC↗ |
| Germano Geno J | Director | P Buy | 2026-09-25 | 2026-09-29 | 2,609 | $6.28 | $16.4K | 47,492 | SEC↗ |
| Brown Melinda | Director | P Buy | 2026-09-25 | 2026-09-29 | 1,135 | $6.27 | $7.1K | 45,481 | SEC↗ |
| Buehler Kevin | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 20,979 | — | $0 | 20,979 | SEC↗ |
| Pire Shari Lisa | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 20,979 | — | $0 | 20,979 | SEC↗ |
| Germano Geno J | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 20,979 | — | $0 | 20,979 | SEC↗ |
| Frankel Stanley | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 20,979 | — | $0 | 20,979 | SEC↗ |
| Brown Melinda | Director | A Award deriv | 2026-06-03 | 2026-06-05 | 20,979 | — | $0 | 20,979 | SEC↗ |
| Amoroso Michael | President and CEO | A Award deriv | 2026-06-01 | 2026-06-03 | 573,888 | — | $0 | 573,888 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award deriv | 2026-06-01 | 2026-06-03 | 193,688 | — | $0 | 193,688 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award deriv | 2026-06-01 | 2026-06-03 | 107,604 | — | $0 | 107,604 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award deriv | 2026-06-01 | 2026-06-03 | 57,389 | — | $0 | 57,389 | SEC↗ |
| Germano Geno J | Director | M Exercise deriv | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 0 | SEC↗ |
| Pire Shari Lisa | Director | M Exercise deriv | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 0 | SEC↗ |
| Brown Melinda | Director | M Exercise deriv | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 0 | SEC↗ |
| Frankel Stanley | Director | M Exercise deriv | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 0 | SEC↗ |
| Buehler Kevin | Director | M Exercise deriv | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 0 | SEC↗ |
| Germano Geno J | Director | M Exercise | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 44,883 | SEC↗ |
| Pire Shari Lisa | Director | M Exercise | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 35,028 | SEC↗ |
| Brown Melinda | Director | M Exercise | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 44,346 | SEC↗ |
| Frankel Stanley | Director | M Exercise | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 40,478 | SEC↗ |
| Buehler Kevin | Director | M Exercise | 2026-05-20 | 2026-05-22 | 21,000 | — | $0 | 49,137 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | S Sale | 2026-02-18 | 2026-02-19 | 4,925 | $3.84 | $18.9K | 121,926 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2026-02-18 | 2026-02-19 | 4,925 | $3.84 | $18.9K | 56,457 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | S Sale | 2026-02-18 | 2026-02-19 | 8,149 | $3.84 | $31.3K | 125,883 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2026-02-18 | 2026-02-19 | 20,559 | $3.84 | $78.9K | 243,392 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2026-02-17 | 2026-02-19 | 16,667 | — | $0 | 33,333 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2026-02-17 | 2026-02-19 | 16,667 | — | $0 | 33,333 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2026-02-17 | 2026-02-19 | 27,584 | — | $0 | 55,166 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2026-02-17 | 2026-02-19 | 67,797 | — | $0 | 135,593 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2026-02-17 | 2026-02-19 | 16,667 | — | $0 | 126,851 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2026-02-17 | 2026-02-19 | 16,667 | — | $0 | 61,382 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2026-02-17 | 2026-02-19 | 27,584 | — | $0 | 134,032 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2026-02-17 | 2026-02-19 | 67,797 | — | $0 | 263,951 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2026-01-22 | 2026-01-22 | 34,799 | $4.17 | $145.1K | 196,154 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | S Sale | 2026-01-21 | 2026-01-22 | 10,200 | $4.03 | $41.1K | 110,184 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2026-01-21 | 2026-01-22 | 16,219 | — | $0 | 120,384 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | S Sale | 2026-01-21 | 2026-01-22 | 15,213 | $4.03 | $61.3K | 106,448 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2026-01-21 | 2026-01-22 | 8,854 | $4.03 | $35.7K | 44,715 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2026-01-20 | 2026-01-22 | 2,500 | — | $0 | 0 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2026-01-20 | 2026-01-22 | 16,219 | — | $0 | 16,219 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2026-01-20 | 2026-01-22 | 10,447 | — | $0 | 10,447 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2026-01-20 | 2026-01-22 | 3,888 | — | $0 | 0 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2026-01-20 | 2026-01-22 | 13,900 | — | $0 | 13,901 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2026-01-20 | 2026-01-22 | 26,575 | — | $0 | 26,575 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2026-01-20 | 2026-01-22 | 14,908 | — | $0 | 14,907 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2026-01-20 | 2026-01-22 | 1,978 | — | $0 | 0 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2026-01-20 | 2026-01-22 | 8,425 | — | $0 | 8,425 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2026-01-20 | 2026-01-22 | 69,421 | — | $0 | 69,421 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2026-01-20 | 2026-01-22 | 8,888 | — | $0 | 0 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2026-01-20 | 2026-01-22 | 37,069 | — | $0 | 37,069 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2026-01-20 | 2026-01-22 | 2,500 | — | $0 | 93,718 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2026-01-20 | 2026-01-22 | 10,447 | — | $0 | 104,165 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2026-01-20 | 2026-01-22 | 3,888 | — | $0 | 81,186 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2026-01-20 | 2026-01-22 | 26,575 | — | $0 | 121,661 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2026-01-20 | 2026-01-22 | 13,900 | — | $0 | 95,086 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2026-01-20 | 2026-01-22 | 14,908 | — | $0 | 53,569 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2026-01-20 | 2026-01-22 | 8,425 | — | $0 | 38,661 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2026-01-20 | 2026-01-22 | 1,978 | — | $0 | 30,236 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2026-01-20 | 2026-01-22 | 69,421 | — | $0 | 230,953 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2026-01-20 | 2026-01-22 | 8,888 | — | $0 | 124,463 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2026-01-20 | 2026-01-22 | 37,069 | — | $0 | 161,532 | SEC↗ |
| Frankel Stanley | Director | P Buy | 2025-12-16 | 2025-12-17 | 2,700 | $4.70 | $12.7K | 19,478 | SEC↗ |
| Germano Geno J | Director | P Buy | 2025-12-16 | 2025-12-17 | 3,000 | $4.72 | $14.2K | 23,883 | SEC↗ |
| Brown Melinda | Director | P Buy | 2025-12-15 | 2025-12-17 | 1,381 | $4.97 | $6.9K | 23,346 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2025-11-03 | 2025-11-04 | 9,444 | — | $0 | 0 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2025-11-03 | 2025-11-04 | 3,409 | $6.49 | $22.1K | 115,575 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2025-11-03 | 2025-11-04 | 665 | $6.49 | $4.3K | 28,258 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | S Sale | 2025-11-03 | 2025-11-04 | 1,303 | $6.49 | $8.5K | 77,298 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2025-11-02 | 2025-11-04 | 1,835 | — | $0 | 0 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2025-11-02 | 2025-11-04 | 3,605 | — | $0 | 0 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2025-11-02 | 2025-11-04 | 9,444 | — | $0 | 118,984 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2025-11-02 | 2025-11-04 | 1,835 | — | $0 | 28,923 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2025-11-02 | 2025-11-04 | 3,605 | — | $0 | 78,601 | SEC↗ |
| Frankel Stanley | Director | P Buy | 2025-09-26 | 2025-09-30 | 2,700 | $4.97 | $13.4K | 16,778 | SEC↗ |
| Brown Melinda | Director | P Buy | 2025-09-22 | 2025-09-24 | 1,400 | $4.89 | $6.8K | 21,965 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | S Sale | 2025-07-03 | 2025-07-08 | 14,827 | $4.26 | $63.2K | 73,485 | SEC↗ |
| Buehler Kevin | Director | P Buy | 2025-06-25 | 2025-06-27 | 5,076 | $4.16 | $21.1K | 28,137 | SEC↗ |
| Brown Melinda | Director | P Buy | 2025-06-25 | 2025-06-27 | 1,682 | $4.14 | $7.0K | 20,565 | SEC↗ |
| Brown Melinda | Director | A Award deriv | 2025-06-03 | 2025-06-04 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Buehler Kevin | Director | A Award deriv | 2025-06-03 | 2025-06-04 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Frankel Stanley | Director | A Award deriv | 2025-06-03 | 2025-06-04 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Pire Shari Lisa | Director | A Award deriv | 2025-06-03 | 2025-06-04 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Germano Geno J | Director | A Award deriv | 2025-06-03 | 2025-06-04 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award deriv | 2025-06-02 | 2025-06-04 | 82,750 | — | $0 | 82,750 | SEC↗ |
| Amoroso Michael | President and CEO | A Award deriv | 2025-06-02 | 2025-06-04 | 203,390 | — | $0 | 203,390 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award deriv | 2025-06-02 | 2025-06-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award deriv | 2025-06-02 | 2025-06-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Brown Melinda | Director | M Exercise deriv | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 0 | SEC↗ |
| Buehler Kevin | Director | M Exercise deriv | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 0 | SEC↗ |
| Frankel Stanley | Director | M Exercise deriv | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 0 | SEC↗ |
| Pire Shari Lisa | Director | M Exercise deriv | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 0 | SEC↗ |
| Germano Geno J | Director | M Exercise deriv | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 0 | SEC↗ |
| Brown Melinda | Director | M Exercise | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 18,883 | SEC↗ |
| Buehler Kevin | Director | M Exercise | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 23,061 | SEC↗ |
| Frankel Stanley | Director | M Exercise | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 14,078 | SEC↗ |
| Pire Shari Lisa | Director | M Exercise | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 14,028 | SEC↗ |
| Germano Geno J | Director | M Exercise | 2025-05-27 | 2025-06-04 | 9,826 | — | $0 | 20,883 | SEC↗ |
| Buehler Kevin | Director | P Buy | 2025-03-26 | 2025-03-28 | 4,523 | $4.67 | $21.1K | 13,235 | SEC↗ |
| Brown Melinda | Director | P Buy | 2025-03-26 | 2025-03-28 | 1,839 | $4.75 | $8.7K | 9,057 | SEC↗ |
| Germano Geno J | Director | P Buy | 2025-03-25 | 2025-03-27 | 3,250 | $5.30 | $17.2K | 11,057 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2025-03-24 | 2025-03-25 | 964 | $5.56 | $5.4K | 109,540 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2025-03-21 | 2025-03-25 | 3,417 | — | $0 | 0 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2025-03-21 | 2025-03-25 | 3,417 | — | $0 | 110,504 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | S Sale | 2025-03-04 | 2025-03-05 | 154 | $4.91 | $756 | 87,805 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2025-03-04 | 2025-03-05 | 272 | $4.91 | $1.3K | 25,000 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2025-03-03 | 2025-03-05 | 1,702 | — | $0 | 0 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2025-03-03 | 2025-03-05 | 519 | — | $0 | 0 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2025-03-03 | 2025-03-05 | 919 | — | $0 | 0 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2025-03-03 | 2025-03-05 | 1,702 | — | $0 | 86,256 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2025-03-03 | 2025-03-05 | 519 | — | $0 | 87,959 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2025-03-03 | 2025-03-05 | 919 | — | $0 | 25,272 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | S Sale | 2025-01-22 | 2025-01-22 | 10,287 | $4.79 | $49.3K | 87,440 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2025-01-22 | 2025-01-22 | 8,928 | $4.79 | $42.8K | 24,353 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2025-01-21 | 2025-01-22 | 36,838 | $4.67 | $172.0K | 107,087 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2025-01-20 | 2025-01-22 | 2,500 | — | $0 | 2,500 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2025-01-20 | 2025-01-22 | 10,449 | — | $0 | 20,894 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2025-01-20 | 2025-01-22 | 16,219 | — | $0 | 32,438 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2025-01-20 | 2025-01-22 | 26,575 | — | $0 | 53,150 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2025-01-20 | 2025-01-22 | 13,904 | — | $0 | 27,801 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2025-01-20 | 2025-01-22 | 3,889 | — | $0 | 3,888 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2025-01-20 | 2025-01-22 | 69,421 | — | $0 | 138,842 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2025-01-20 | 2025-01-22 | 37,079 | — | $0 | 74,138 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2025-01-20 | 2025-01-22 | 8,888 | — | $0 | 8,888 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2025-01-20 | 2025-01-22 | 14,908 | — | $0 | 29,815 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2025-01-20 | 2025-01-22 | 1,977 | — | $0 | 1,978 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2025-01-20 | 2025-01-22 | 8,427 | — | $0 | 16,850 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2025-01-20 | 2025-01-22 | 29,168 | — | $0 | 97,727 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2025-01-20 | 2025-01-22 | 44,368 | — | $0 | 84,554 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2025-01-20 | 2025-01-22 | 115,388 | — | $0 | 143,925 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2025-01-20 | 2025-01-22 | 25,312 | — | $0 | 33,281 | SEC↗ |
| Germano Geno J | Director | P Buy | 2024-12-30 | 2025-01-02 | 3,605 | $4.49 | $16.2K | 7,807 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | P Buy | 2024-12-27 | 2024-12-31 | 2,113 | $4.75 | $10.0K | 40,186 | SEC↗ |
| Buehler Kevin | Director | P Buy | 2024-12-27 | 2024-12-31 | 4,320 | $4.88 | $21.1K | 8,712 | SEC↗ |
| Brown Melinda | Director | P Buy | 2024-12-26 | 2024-12-30 | 3,016 | $4.55 | $13.7K | 7,218 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | P Buy | 2024-11-21 | 2024-11-21 | 3,000 | $6.76 | $20.3K | 38,073 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2024-11-04 | 2024-11-05 | 3,012 | $8.19 | $24.7K | 28,537 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2024-11-04 | 2024-11-05 | 588 | $8.19 | $4.8K | 7,969 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2024-11-02 | 2024-11-05 | 9,443 | — | $0 | 9,444 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2024-11-02 | 2024-11-05 | 1,836 | — | $0 | 1,835 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2024-11-02 | 2024-11-05 | 3,605 | — | $0 | 3,605 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2024-11-02 | 2024-11-05 | 9,443 | — | $0 | 31,549 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2024-11-02 | 2024-11-05 | 1,836 | — | $0 | 8,557 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2024-11-02 | 2024-11-05 | 3,605 | — | $0 | 35,073 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award deriv | 2024-08-22 | 2024-08-23 | 44,723 | — | $0 | 44,723 | SEC↗ |
| Amoroso Michael | President and CEO | A Award deriv | 2024-08-22 | 2024-08-23 | 208,263 | — | $0 | 208,263 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award deriv | 2024-08-22 | 2024-08-23 | 79,725 | — | $0 | 79,725 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award deriv | 2024-08-22 | 2024-08-23 | 48,657 | — | $0 | 48,657 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | S Sale | 2024-06-10 | 2024-06-11 | 50 | $11.79 | $590 | 68,559 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2024-06-10 | 2024-06-11 | 93 | $11.79 | $1.1K | 6,721 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2024-06-07 | 2024-06-11 | 163 | — | $0 | 0 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2024-06-07 | 2024-06-11 | 454 | — | $0 | 0 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2024-06-07 | 2024-06-11 | 301 | — | $0 | 0 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2024-06-07 | 2024-06-11 | 163 | — | $0 | 68,609 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2024-06-07 | 2024-06-11 | 454 | — | $0 | 31,468 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2024-06-07 | 2024-06-11 | 301 | — | $0 | 6,814 | SEC↗ |
| Wadsworth Samuel C. | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 9,826 | — | $0 | 9,826 | SEC↗ |
| Pire Shari Lisa | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 9,826 | — | $0 | 9,826 | SEC↗ |
| Germano Geno J | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 9,826 | — | $0 | 9,826 | SEC↗ |
| Frankel Stanley | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 9,826 | — | $0 | 9,826 | SEC↗ |
| Buehler Kevin | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 9,826 | — | $0 | 9,826 | SEC↗ |
| Brown Melinda | Director | A Award deriv | 2024-06-04 | 2024-06-06 | 9,826 | — | $0 | 9,826 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award | 2024-05-08 | 2024-05-08 | 833 | $12.00 | $10.0K | 6,513 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award | 2024-05-08 | 2024-05-08 | 833 | $12.00 | $10.0K | 68,446 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award | 2024-05-08 | 2024-05-08 | 8,334 | $12.00 | $100.0K | 31,014 | SEC↗ |
| Amoroso Michael | President and CEO | A Award | 2024-05-08 | 2024-05-08 | 8,334 | $12.00 | $100.0K | 22,106 | SEC↗ |
| Brown Melinda | Director | M Exercise deriv | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 0 | SEC↗ |
| Frankel Stanley | Director | M Exercise deriv | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 0 | SEC↗ |
| Germano Geno J | Director | M Exercise deriv | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 0 | SEC↗ |
| Wadsworth Samuel C. | Director | M Exercise deriv | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 0 | SEC↗ |
| Buehler Kevin | Director | M Exercise deriv | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 0 | SEC↗ |
| Pire Shari Lisa | Director | M Exercise deriv | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 0 | SEC↗ |
| Brown Melinda | Director | M Exercise | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 4,202 | SEC↗ |
| Frankel Stanley | Director | M Exercise | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 4,252 | SEC↗ |
| Germano Geno J | Director | M Exercise | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 4,202 | SEC↗ |
| Wadsworth Samuel C. | Director | M Exercise | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 4,202 | SEC↗ |
| Buehler Kevin | Director | M Exercise | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 4,392 | SEC↗ |
| Pire Shari Lisa | Director | M Exercise | 2024-05-04 | 2024-05-07 | 4,202 | — | $0 | 4,202 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2024-05-02 | 2024-05-03 | 1,526 | $10.32 | $15.7K | 13,772 | SEC↗ |
| List Alan | Chief Medical Officer | S Sale | 2024-05-02 | 2024-05-03 | 290 | $10.32 | $3.0K | 4,488 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | S Sale | 2024-05-02 | 2024-05-03 | 154 | $10.32 | $1.6K | 67,613 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2024-05-02 | 2024-05-03 | 272 | $10.32 | $2.8K | 5,680 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2024-05-01 | 2024-05-03 | 3,417 | — | $0 | 3,417 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise deriv | 2024-05-01 | 2024-05-03 | 982 | — | $0 | 981 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2024-05-01 | 2024-05-03 | 519 | — | $0 | 519 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale deriv | 2024-05-01 | 2024-05-03 | 918 | — | $0 | 919 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2024-05-01 | 2024-05-03 | 1,702 | — | $0 | 1,702 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2024-05-01 | 2024-05-03 | 3,417 | — | $0 | 15,298 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise | 2024-05-01 | 2024-05-03 | 982 | — | $0 | 4,778 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2024-05-01 | 2024-05-03 | 519 | — | $0 | 67,767 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2024-05-01 | 2024-05-03 | 918 | — | $0 | 5,952 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2024-05-01 | 2024-05-03 | 1,702 | — | $0 | 22,680 | SEC↗ |
| List Alan | Chief Medical Officer | S Sale | 2024-04-30 | 2024-04-30 | 238 | $10.03 | $2.4K | 3,796 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise deriv | 2024-04-26 | 2024-04-30 | 868 | — | $0 | 0 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise | 2024-04-26 | 2024-04-30 | 868 | — | $0 | 4,034 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award deriv | 2024-04-18 | 2024-04-22 | 41,705 | — | $0 | 41,705 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award deriv | 2024-04-18 | 2024-04-22 | 25,277 | — | $0 | 25,277 | SEC↗ |
| Amoroso Michael | President and CEO | A Award deriv | 2024-04-18 | 2024-04-22 | 111,217 | — | $0 | 111,217 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award deriv | 2024-04-18 | 2024-04-22 | 31,343 | — | $0 | 31,343 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award | 2024-02-29 | 2024-05-03 | 1,006 | $12.42 | $12.5K | 67,248 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award | 2024-02-29 | 2024-05-03 | 506 | $18.50 | $9.4K | 20,978 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | S Sale | 2024-01-23 | 2024-01-23 | 28,000 | $0.37 | $10.4K | 1,987,269 | SEC↗ |
| List Alan | Chief Medical Officer | S Sale | 2024-01-22 | 2024-01-23 | 21,526 | $0.36 | $7.7K | 94,982 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2024-01-22 | 2024-01-23 | 21,287 | $0.36 | $7.7K | 151,028 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2024-01-22 | 2024-01-23 | 137,390 | $0.36 | $49.5K | 356,433 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2024-01-20 | 2024-01-23 | 75,015 | — | $0 | 149,985 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise deriv | 2024-01-20 | 2024-01-23 | 60,012 | — | $0 | 119,988 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2024-01-20 | 2024-01-23 | 59,345 | — | $0 | 118,655 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2024-01-20 | 2024-01-23 | 266,720 | — | $0 | 533,280 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2024-01-20 | 2024-01-23 | 116,690 | — | $0 | 233,310 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2024-01-20 | 2024-01-23 | 75,015 | — | $0 | 2,015,269 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise | 2024-01-20 | 2024-01-23 | 60,012 | — | $0 | 116,508 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2024-01-20 | 2024-01-23 | 59,345 | — | $0 | 172,315 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2024-01-20 | 2024-01-23 | 266,720 | — | $0 | 493,823 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2024-01-20 | 2024-01-23 | 116,690 | — | $0 | 614,169 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2023-11-03 | 2023-11-06 | 125,025 | $0.40 | $50.0K | 227,103 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2023-11-03 | 2023-11-06 | 16,023 | $0.40 | $6.4K | 112,970 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2023-11-02 | 2023-11-06 | 108,188 | — | $0 | 216,312 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2023-11-02 | 2023-11-06 | 283,390 | — | $0 | 566,610 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2023-11-02 | 2023-11-06 | 55,077 | — | $0 | 110,123 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2023-11-02 | 2023-11-06 | 108,188 | — | $0 | 497,479 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2023-11-02 | 2023-11-06 | 283,390 | — | $0 | 352,128 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2023-11-02 | 2023-11-06 | 55,077 | — | $0 | 128,993 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award | 2023-08-31 | 2023-09-05 | 5,951 | $0.39 | $2.3K | 389,291 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award | 2023-08-31 | 2023-09-05 | 5,175 | $0.39 | $2.0K | 1,940,254 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award | 2023-08-31 | 2023-09-05 | 5,443 | $0.39 | $2.1K | 73,916 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | P Buy | 2023-08-18 | 2023-10-27 | 90,000 | $0.48 | $43.2K | 383,340 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award | 2023-08-18 | 2023-08-22 | 90,000 | $0.48 | $43.2K | 383,340 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2023-06-08 | 2023-06-09 | 13,361 | $0.75 | $10.0K | 68,473 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2023-06-07 | 2023-06-09 | 9,044 | — | $0 | 9,045 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2023-06-07 | 2023-06-09 | 22,727 | — | $0 | 0 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2023-06-07 | 2023-06-09 | 4,872 | — | $0 | 4,872 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2023-06-07 | 2023-06-09 | 13,635 | — | $0 | 13,635 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2023-06-07 | 2023-06-09 | 34,091 | — | $0 | 0 | SEC↗ |
| Barton Shane | VP & Corporate Controller | M Exercise deriv | 2023-06-07 | 2023-06-09 | 6,060 | — | $0 | 6,060 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2023-06-07 | 2023-06-09 | 9,044 | — | $0 | 81,834 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2023-06-07 | 2023-06-09 | 22,727 | — | $0 | 72,790 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2023-06-07 | 2023-06-09 | 4,872 | — | $0 | 1,935,079 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2023-06-07 | 2023-06-09 | 34,091 | — | $0 | 279,705 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2023-06-07 | 2023-06-09 | 13,635 | — | $0 | 293,340 | SEC↗ |
| Barton Shane | VP & Corporate Controller | M Exercise | 2023-06-07 | 2023-06-09 | 6,060 | — | $0 | 27,502 | SEC↗ |
| Germano Geno J | Director | A Award deriv | 2023-05-04 | 2023-05-08 | 126,075 | — | $0 | 126,075 | SEC↗ |
| Brown Melinda | Director | A Award deriv | 2023-05-04 | 2023-05-08 | 126,075 | — | $0 | 126,075 | SEC↗ |
| Pire Shari Lisa | Director | A Award deriv | 2023-05-04 | 2023-05-08 | 126,075 | — | $0 | 126,075 | SEC↗ |
| Buehler Kevin | Director | A Award deriv | 2023-05-04 | 2023-05-08 | 126,075 | — | $0 | 126,075 | SEC↗ |
| Frankel Stanley | Director | A Award deriv | 2023-05-04 | 2023-05-08 | 126,075 | — | $0 | 126,075 | SEC↗ |
| Wadsworth Samuel C. | Director | A Award deriv | 2023-05-04 | 2023-05-08 | 126,075 | — | $0 | 126,075 | SEC↗ |
| List Alan | Chief Medical Officer | S Sale | 2023-04-27 | 2023-04-28 | 7,771 | $0.79 | $6.1K | 56,496 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise deriv | 2023-04-26 | 2023-04-28 | 26,027 | — | $0 | 26,028 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise | 2023-04-26 | 2023-04-28 | 26,027 | — | $0 | 64,267 | SEC↗ |
| Buehler Kevin | Director | M Exercise deriv | 2023-04-11 | 2023-04-13 | 5,701 | — | $0 | 0 | SEC↗ |
| Buehler Kevin | Director | M Exercise | 2023-04-11 | 2023-04-13 | 5,701 | — | $0 | 5,701 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2023-03-22 | 2023-03-23 | 46,999 | $0.82 | $38.5K | 68,738 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2023-03-21 | 2023-03-23 | 102,535 | — | $0 | 205,009 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2023-03-21 | 2023-03-23 | 102,535 | — | $0 | 115,737 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | P Buy | 2023-03-17 | 2023-03-21 | 20,000 | $0.86 | $17.2K | 245,614 | SEC↗ |
| List Alan | Chief Medical Officer | S Sale | 2023-03-06 | 2023-03-07 | 9,473 | $1.07 | $10.1K | 38,240 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2023-03-06 | 2023-03-07 | 12,172 | $1.07 | $13.0K | 50,063 | SEC↗ |
| Barton Shane | VP & Corporate Controller | M Exercise deriv | 2023-03-03 | 2023-03-07 | 12,722 | — | $0 | 25,439 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2023-03-03 | 2023-03-07 | 51,071 | — | $0 | 102,114 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise deriv | 2023-03-03 | 2023-03-07 | 15,576 | — | $0 | 31,144 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise deriv | 2023-03-03 | 2023-03-07 | 29,453 | — | $0 | 58,890 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2023-03-03 | 2023-03-07 | 27,558 | — | $0 | 55,101 | SEC↗ |
| Barton Shane | VP & Corporate Controller | M Exercise | 2023-03-03 | 2023-03-07 | 12,722 | — | $0 | 21,422 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise | 2023-03-03 | 2023-03-07 | 51,071 | — | $0 | 225,614 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | M Exercise | 2023-03-03 | 2023-03-07 | 15,576 | — | $0 | 1,930,207 | SEC↗ |
| List Alan | Chief Medical Officer | M Exercise | 2023-03-03 | 2023-03-07 | 29,453 | — | $0 | 47,713 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise | 2023-03-03 | 2023-03-07 | 27,558 | — | $0 | 62,235 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award | 2023-02-28 | 2023-03-07 | 11,605 | $0.95 | $11.0K | 174,543 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award | 2023-02-28 | 2023-03-07 | 12,157 | $0.95 | $11.5K | 1,914,631 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award | 2023-02-28 | 2023-03-07 | 2,163 | $0.95 | $2.1K | 34,677 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award deriv | 2023-01-20 | 2023-01-24 | 178,000 | — | $0 | 178,000 | SEC↗ |
| List Alan | Chief Medical Officer | A Award deriv | 2023-01-20 | 2023-01-24 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Amoroso Michael | President and CEO | A Award deriv | 2023-01-20 | 2023-01-24 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Barton Shane | VP & Corporate Controller | A Award deriv | 2023-01-20 | 2023-01-24 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award deriv | 2023-01-20 | 2023-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| SMITH J. JEFFERSON | Chief Research Officer | A Award deriv | 2023-01-20 | 2023-01-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Amoroso Michael | President and CEO | A Award deriv | 2022-11-02 | 2022-11-04 | 850,000 | — | $0 | 850,000 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | A Award deriv | 2022-11-02 | 2022-11-04 | 324,500 | — | $0 | 324,500 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | A Award deriv | 2022-11-02 | 2022-11-04 | 165,200 | — | $0 | 165,200 | SEC↗ |
| Amoroso Michael | President and CEO | A Award deriv | 2022-10-24 | 2022-10-26 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Amoroso Michael | President and CEO | S Sale | 2022-10-17 | 2022-10-18 | 11,006 | $1.32 | $14.5K | 13,202 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise deriv | 2022-10-15 | 2022-10-18 | 24,208 | — | $0 | 0 | SEC↗ |
| Amoroso Michael | President and CEO | M Exercise | 2022-10-15 | 2022-10-18 | 24,208 | — | $0 | 24,208 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | P Buy | 2022-09-23 | 2022-09-26 | 8,200 | $1.23 | $10.1K | 162,938 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | P Buy | 2022-09-22 | 2022-09-26 | 37,037 | $1.34 | $49.6K | 154,738 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | P Buy | 2022-06-22 | 2022-06-24 | 33,784 | $1.50 | $50.7K | 117,701 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | S Sale | 2022-06-08 | 2022-06-09 | 9,833 | $2.06 | $20.3K | 32,514 | SEC↗ |
| JANTZ DEREK | Chief Scientific Officer | S Sale | 2022-06-08 | 2022-06-09 | 18,849 | $2.06 | $38.8K | 4,055,174 | SEC↗ |
| Barton Shane | VP & Corporate Controller | M Exercise deriv | 2022-06-07 | 2022-06-09 | 6,061 | — | $0 | 12,120 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2022-06-07 | 2022-06-09 | 13,638 | — | $0 | 27,270 | SEC↗ |
| Kelly John Alexander | Chief Financial Officer | M Exercise deriv | 2022-06-07 | 2022-06-09 | 34,090 | — | $0 | 34,091 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2022-06-07 | 2022-06-09 | 22,727 | — | $0 | 22,727 | SEC↗ |
| Scimeca Dario | General Counsel and Secretar | M Exercise deriv | 2022-06-07 | 2022-06-09 | 9,047 | — | $0 | 18,089 | SEC↗ |
| JANTZ DEREK | Chief Scientific Officer | M Exercise deriv | 2022-06-07 | 2022-06-09 | 29,545 | — | $0 | 29,545 | SEC↗ |
| JANTZ DEREK | Chief Scientific Officer | M Exercise deriv | 2022-06-07 | 2022-06-09 | 12,199 | — | $0 | 24,391 | SEC↗ |
| Barton Shane | VP & Corporate Controller | M Exercise | 2022-06-07 | 2022-06-09 | 6,061 | — | $0 | 8,720 | SEC↗ |